PCM
IMDX

Prelude Capital Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History

Prelude Capital Management’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16
Closed -$1K – 1584
2019
Q1 		$1K Buy
+16
New +$1K ﹤0.01% 1302